Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The most comprehensive study ever conducted of lung cancer diagnosis in England has revealed significant disparities between ethnic groups and striking evidence that people living in the most deprived areas were diagnosed with lung cancer at twice the rate of those in affluent areas.

A stethoscope and doctor's notes

The study, published in The Lancet Regional Health - Europe, which is the largest of its kind analysed health records of over 17.5 million people and more than 84,000 lung cancer cases, found that Bangladeshi men had the highest rates of lung cancer, while people from the most deprived areas developed the disease at twice the rate of  those from affluent areas.

Among those who developed lung cancer, people from deprived areas had a 35% higher risk of being diagnosed with more aggressive forms of the disease.

Researchers from Oxford's Nuffield Department of Primary Care Health Sciences found clear evidence that different ethnic groups show distinct patterns of lung cancer types, with important implications for screening and early detection.

Professor Julia Hippisley-Cox, senior author of the study, said: 'This research provides the strongest evidence yet of how your ethnic background and social circumstances affect both your risk of developing lung cancer and the type of cancer you may develop. These findings are particularly timely as the NHS rolls out its targeted lung cancer screening programme.'

 

Read the full story on the University of Oxford website.

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience